Dysplasia and cancer in inflammatory bowel disease

References

• Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. 1932. Mt Sinai J. Med.67, 263–268 (2000).
   PubMedGoogle Scholar
• Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer48, 2742–2745 (1981).
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Cancer risk in ulcerative colitis: surveillance or surgery. Br. J. Surg.72(Suppl.), S84–S86 (1985).
   Web of Science ®Google Scholar
• Dawson IM, Pryse-Davies J. The development of carcinoma of the large intestine in ulcerative colitis. Br. J. Surg.47, 113–128 (1959).
   PubMed Web of Science ®Google Scholar
• Brostrom O, Lofbberg R, Nordenvall B et al. The risk of colorectal cancer in ulcerative colitis: an epidemiologic study. Scand. J. Gastroenterol.22, 1193–1199 (1987).
   PubMed Web of Science ®Google Scholar
• Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis: results from a surveillance program. Dig. Dis. Sci.34, 1536–1541 (1989).
   PubMedGoogle Scholar
• Friedman S, Rubin PH, Bodian C et al. Screening and surveillance colonoscopy in chronic Crohn’s colitis. Gastroenterology120, 820–826 (2001).
   PubMedGoogle Scholar
• Sachar DB. Cancer in ulcerative colitis: good news and bad news. Ann. Intern. Med.95, 642–643 (1981).
   PubMedGoogle Scholar
• Maratka Z, Nebdal J, Kocianova J et al. Incidence of colorectal cancer in proctocolitis. A retrospective study of 959 cases of over 40 years. Gut26, 43–49 (1985).
   PubMed Web of Science ®Google Scholar
• Gyde SN, Prior P, Allan RN et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut29(2), 206–217 (1988).
   PubMed Web of Science ®Google Scholar
• Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut48, 526–535 (2001).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Blanchard JF, Kliewer E et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer91, 854–862 (2001).
   PubMed Web of Science ®Google Scholar
• Winther KV, Jess T, Langholz E, Munkholm P, Binder V. Longterm risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin. Gastroenterol. Hepatol.2, 1088–1095 (2004).
   PubMed Web of Science ®Google Scholar
• Lakatos L, Mester G, Erdelyi Z et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm. Bowel Dis.12(3), 205–211 (2006).
   PubMed Web of Science ®Google Scholar
• Koobatian GJ, Choi PM. Safety of surveillance colonoscopy in long-standing ulcerative colitis. Am. J. Gastroenterol.898, 1472–1475 (1994).
   Google Scholar
• Rozen P, Baratz M, Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology108, 1361–1370 (1995).
   PubMedGoogle Scholar
• Lofberg R, Brostrom O, Karlen P et al. Colonoscopic surveillance in long-standing total ulcerative colitis. Gastroenterology99, 1021–1031 (1990).
   PubMed Web of Science ®Google Scholar
• Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: a critical review. N. Engl. J. Med.316, 1654–1658 (1987).
   PubMed Web of Science ®Google Scholar
• Choi PM, Nugent FW, Schoetz DJ Jr et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology105, 418–424 (1993).
   PubMed Web of Science ®Google Scholar
• Nugent FW, Haggit RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology100, 1241–1248 (1991).
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm. Bowel Dis.11, 314–321 (2005).
   PubMed Web of Science ®Google Scholar
• Warren S, Sommers SC. Cicatrizing enteritis as a pathological entity; analysis of one hundred and twenty cases. Am. J. Pathol.24, 475–501 (1948).
   PubMedGoogle Scholar
• Rubio CA, Befrits R. Colorectal adenocarcinoma in Crohn’s disease: a retrospective histologic study. Dis. Colon Rectum40, 1072–1078 (1990).
   Google Scholar
• Hamilton SR. Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology89, 398–407 (1985).
   PubMed Web of Science ®Google Scholar
• Shorter RG. Risk of intestinal cancer in Crohn’s disease. Dis. Colon Rectum26, 686–690 (1983).
   PubMedGoogle Scholar
• Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignancies in Crohn’s disease: a 20-year experience. Dis. Colon Rectum33, 7–11 (1990).
   PubMedGoogle Scholar
• Richards ME, Rickert RR, Nance FC. Crohn’s disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann. Surg.209, 764–773 (1989).
   PubMedGoogle Scholar
• Weedon DD, Shorter RG, Ilstrup DM et al. Crohn’s disease and cancer. N. Engl. J. Med.289, 1099–1102 (1973).
   PubMed Web of Science ®Google Scholar
• Gillen CD, Prior P, Andrews HA. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive ulcerative colitis. Gut35, 1590–1592 (1994).
   PubMed Web of Science ®Google Scholar
• Sachar DB. Cancer in Crohn’s disease: dispelling the myths. Gut35, 1507–1508 (1994).
   PubMed Web of Science ®Google Scholar
• Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment. Pharmacol. Ther.23, 1097–1104 (2006).
   PubMed Web of Science ®Google Scholar
• Choi PM, Zelig, MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut35, 950 (1994).
   PubMed Web of Science ®Google Scholar
• Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn disease – based on results from a regional patient group from the county of Copenhagen. Gut26, 146–150 (1985).
   PubMed Web of Science ®Google Scholar
• Kvist N, Jacobsen O, Norgaard P et al. Malignancy in Crohn’s disease. Scand. J. Gastroenterol.21, 82–86 (1986).
   PubMed Web of Science ®Google Scholar
• Gollop JH, Phillips SF, Melton U III et al. Epidemiologic aspects of Crohn’s disease. Gut29, 49–56 (1988).
   PubMed Web of Science ®Google Scholar
• Rubin DT, Parekh N. Colorectal cancer in inflammatory bowel disease: molecular and clinical considerations. Curr. Treat. Options Gastroenterol.9, 211–220 (2006).
   PubMedGoogle Scholar
• Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM, Lindor NM. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case–control study. Gastroenterology115, 1079–1083 (1998).
   PubMed Web of Science ®Google Scholar
• Askling J, Dickman PW, Karlen P et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology120, 1356–1362 (2001).
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Davidsen M. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology105, 1716–1723 (1993).
   PubMed Web of Science ®Google Scholar
• Basseri RJ, Basseri B, Ippoliti A et al. The efficacy of colorectal cancer surveillance in Crohn’s colitis. Gastroenterology138(5 Suppl. 1), S443 (2010).
   Google Scholar
• Rutter M, Saunders B, Wilkinson K et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology126, 451–459 (2004).
   PubMed Web of Science ®Google Scholar
• Broome U, Olsson R, Loof L et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut38, 610–615 (1996).
   PubMed Web of Science ®Google Scholar
• Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut48, 430–434 (2001).
   PubMed Web of Science ®Google Scholar
• Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut41, 522–525 (1997).
   PubMed Web of Science ®Google Scholar
• Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest. Endosc.56, 48–54 (2002).
   PubMed Web of Science ®Google Scholar
• Binder V. Cancer in inflammatory bowel disease. In: Clinical Diagnosis and Management. Rampton D (Ed.). Martin Dunitz, London, UK (2000).
   Google Scholar
• Broomé U, Löfberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis. Colon Rectum38(12), 1301–1305 (1995).
   PubMed Web of Science ®Google Scholar
• Mathy C, Schneider K, Chen YY et al. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm. Bowel Dis.9, 351–355 (2003).
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M et al. Increased risk of large bowel cancer in Crohn’s disease with colonic involvement. Lancet336, 357–359 (1990).
   PubMed Web of Science ®Google Scholar
• Gupta RB, Harpaz N, Itzkowitz S et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology133(4), 1099–1105; quiz 1340–1341 (2007).
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology126, 1634–1648 (2004).
   PubMed Web of Science ®Google Scholar
• Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol.14, 931–968 (1983).
   PubMed Web of Science ®Google Scholar
• Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case–control study of 32,702 veterans. Ann. Intern. Med.123, 904–910 (1995).
   PubMed Web of Science ®Google Scholar
• Collins PD, Mpofu C, Watson AJ et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst. Rev.19, CD000279 (2006).
   Google Scholar
• Hanauer SB, Meyers S. Management of Crohn’s disease in adults. Am. J. Gastroenterol.92, 559–566 (1997).
   PubMed Web of Science ®Google Scholar
• Soetikno R, Friedland S, Kaltenbach T et al. Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology130, 566–576; quiz 588–589 (2006).
   PubMed Web of Science ®Google Scholar
• Kottachchi D, Yung D, Marshall JK. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital. Can. J. Gastroenterol.23, 613–617 (2009).
   PubMed Web of Science ®Google Scholar
• Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am. J. Gastroenterol.96, 2929–2933 (2001).
   PubMed Web of Science ®Google Scholar
• Cervený P, Bortlík M, Kubena A, Vlcek J, Lakatos PL, Lukás M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm. Bowel Dis.13, 1244–1249 (2007).
   PubMed Web of Science ®Google Scholar
• Sewitch MJ, Abrahamowicz M, Barkun A et al. Patient nonadherence to medication in inflammatory bowel disease. Am. J. Gastroenterol.98, 1535–1544 (2003).
   PubMed Web of Science ®Google Scholar
• Rubin G, Hungin AP, Chinn D, Dwarakanath AD, Green L, Bates J. Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey. Aliment. Pharmacol. Ther.16, 1889–1893 (2002).
   PubMed Web of Science ®Google Scholar
• Lakatos PL. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J. Gastroenterol.15, 4234–4239 (2009).
   PubMed Web of Science ®Google Scholar
• Connell WR, Lennard-Jones JE, Williams CB et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology107, 934–944 (1994).
   PubMed Web of Science ®Google Scholar
• Lashner BA, Provencher KS, Bozdech JM et al. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Am. J. Gastroenterol.90, 377–380 (1995).
   PubMed Web of Science ®Google Scholar
• Ullman T, Croog V, Harpaz N et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology125, 1311–1319 (2003).
   PubMed Web of Science ®Google Scholar
• van Rijn JC, Reitsma JB, Stoker J et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am. J. Gastroenterol.101, 343–350 (2006).
   PubMed Web of Science ®Google Scholar
• Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology112, 24–28 (1997).
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Nugent PA, Mysliwiec PA et al. Location of adenomas missed by optical colonoscopy. Ann. Intern. Med.141, 352–359 (2004).
   PubMed Web of Science ®Google Scholar
• Leaper M, Johnston MJ, Barclay M et al. Reasons for failure to diagnose colorectal carcinoma at colonoscopy. Endoscopy36, 499–503 (2004).
   PubMed Web of Science ®Google Scholar
• Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology124, 880–888 (2003).
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Schofield G et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut53, 256–260 (2004).
   PubMed Web of Science ®Google Scholar
• Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest. Endosc.44, 8–14 (1996).
   PubMed Web of Science ®Google Scholar
• Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy37, 1186–1192 (2005).
   PubMed Web of Science ®Google Scholar
• Gono K, Obi T, Yamaguchi M et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J. Biomed. Opt.9, 568–577 (2004).
   PubMed Web of Science ®Google Scholar
• Dekker E, van den Broek FJ, Reitsma JB et al. Endoscopy. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. 39, 216–221 (2007).
   Google Scholar
• Chiu HM, Chang CY, Chen CC et al. A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia. Gut56, 373–379 (2007).
   PubMed Web of Science ®Google Scholar
• Hoffman A, Goetz M, Vieth M, Galle PR, Neurath MF, Kiesslich R. Confocal laser endomicroscopy: technical status and current indications. Endoscopy38, 1275–1283 (2006).
   PubMedGoogle Scholar
• Goetz M, Toermer T, Vieth M et al. Simultaneous confocal laser endomicroscopy and chromoendoscopy with topical cresyl violet. Gastrointest. Endosc.70, 959–968 (2009).
   PubMedGoogle Scholar
• Kiesslich R, Goetz M, Lammersdorf K et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology132, 874–882 (2007).
   PubMed Web of Science ®Google Scholar
• Hurlstone DP, Thomson M, Brown S, Tiffin N, Cross SS, Hunter MD. Confocal endomicroscopy in ulcerative colitis: differentiating dysplasia-associated lesional mass and adenoma-like mass. Clin. Gastroenterol. Hepatol.5, 1235–1241 (2007).
   PubMed Web of Science ®Google Scholar
• Georgakoudi I, Jacobson BC, van Dam J et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett’s esophagus. Gastroenerology120, 1620–1629 (2001).
   PubMed Web of Science ®Google Scholar
• Haringsma J, Tytgat GN, Yano H et al. Autofluorescence endoscopy. Feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest. Endosc.53, 642–650 (2001).
   PubMed Web of Science ®Google Scholar
• Ueno N, Iishi H, Tatsuta M et al. A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers. Gastrointest. Endosc.62, 521–528 (2005).
   PubMedGoogle Scholar
• Matsumoto T, Moriyama T, Yao T, Mibu R, Iida M. Autofluorescence imaging colonoscopy for the diagnosis of dysplasia in ulcerative colitis. Inflamm. Bowel Dis.13, 640–641 (2007).
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Nakamura S, Moriyama T, Hirahashi M, Iida M. Auto-fluorescence imaging colonoscopy for the detection of dysplastic lesions in ulcerative colitis: a pilot study. Colorectal Dis. DOI: 10.1111/j.1463-1318.2009.02181.x (2009) (Epub ahead of print).
   Google Scholar
• Velayos FS, Loftus> EV Jr, Jess T et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case–control study. Gastroenterology130, 1941–1949 (2006).
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology103, 1444–1451 (1992).
   PubMed Web of Science ®Google Scholar
• Langholz E. Ulcerative colitis. An epidemiological observational study based on a regional inception cohort, with special reference to disease course and prognosis. Dan. Med. Bull.46, 400–415 (1999).
   PubMed Web of Science ®Google Scholar
• Actis GC, Pellicano R, David E, Sapino A. Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast. Inflamm. Allergy Drug Targets9, 6–9 (2010).
   PubMedGoogle Scholar
• Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am. J. Gastroenterol.100, 1345–1353 (2005).
   PubMed Web of Science ®Google Scholar
• Tang J, Sharif O, Pai C, Silverman AL. Mesalamine protects against colorectal cancer in inflammatory bowel disease. Dig. Dis. Sci.55(6), 1696–1703 (2009).
   PubMedGoogle Scholar
• Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology97, 255–259 (1989).
   PubMed Web of Science ®Google Scholar
• Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology112, 29–32 (1997).
   PubMed Web of Science ®Google Scholar
• Tung BY, Emond MJ, Haggitt RC et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann. Intern. Med.134, 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology124, 889–893 (2003).
   PubMed Web of Science ®Google Scholar
• Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study. Anticancer Res.24, 3121–3127 (2004).
   PubMed Web of Science ®Google Scholar